MACULAR EDEMA TREATMENT IN DIABETIC RETINOPATHY
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Macular edema represents a common clinical complication in diabetic patients with reti- nopathy. The risk for a diabetic patient to develop macular edema is around 10%. Al- though the precise etiology of macular edema is not completely known, understanding its pathogenic mechanisms could help in developing new therapeutic procedures. Keep- ing the common risk factors under control is of crucial importance in the prevention and management of ocular complications. As regards the treatment of these complications, current literature recommends laser therapy as the gold-standard. The aim of this article is to examine all the therapeutic possibilities by describing the advantages and disadvan- tages of each methodology.
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.